ZERONA®

AMAZING ZERONA® 'LIPO-LASER' FOR NON-SURGICAL LIPOSUCTION

The first FDA approved, non-invasive body contouring procedure proven both safe and effective at removing unwanted fat and inches. ZERONA® is the safest and most researched low-level laser in the world, allowing physicians to offer a painless alternative to liposuction. More specifically, ZERONA® has been approved by the FDA for the elimination of fat and reduction of waist, hips and thighs. In a double blind, randomized, placebo controlled study, patients were treated 6 times over a 2 week period with Zerona - a patented low-level laser system - and lost on average 3.5 inches in combined circumferential measurements of their waist hips and bilateral thighs.

How the Zerona® Fat Loss Procedure Works:

The Zerona® procedure is designed to complement a healthy diet and exercise regimen, and can help men and women lose unwanted inches and body fat in several areas of the body, including the hips, thighs, waist, stomach, arms and back. Unlike liposuction and some body contouring procedures, Zerona is applied externally with a laser beam directed onto the skin. The laser device used in the Zerona system is a variable frequency, five-diode laser that delivers varying wavelengths of energy into the skin. The laser is applied to the targeted area for a total of 40 minutes, usually 20 minutes on each side of the body. The laser works to emulsify the adipose tissue, and releases it into the empty space between the body cells. As long as the patient maintains a healthy diet and sticks with a consistent workout program throughout the treatment process, this excess fat will be removed naturally through the body’s natural detoxification process.

ZERONA is a revolutionary method that is applied externally without the dangers associated with surgery, while at the same time allowing patients to remain active during treatment Patients are able to continue to their busy lives without pain, swelling or the discomfort of garments.

History of ZERONA®

Research began accidentally in 1998 with Dr. Neira, a Columbian Plastic Surgeon who was using LLLT (Low Level Laser Therapy) as an adjunct to surgery in reducing pain and inflammation. When he used LLLT on his liposuction patients, he was surprised to learn that fat extraction was much easier than it should have been, and that the aspirate appeared much smoother than expected. After closer examination, he was able to determine that stimulation of the adipocyte cell by the low-level laser helped emulsify that fat within the cell and created a small temporary opening, allowing for the fatty contents to seep out from the fat cell. Once liberated, triglycerides are broken down through the lymphatic system before entering the bloodstream where they can either be used to fuel normal metabolic needs or processed by the liver and excreted. This process left a smaller, collapsed treated cells, resulting in circumferential loss of the treated areas. It was this finding back in 1998, that led to numerous clinical trials and studies that demonstrated the safety and effectiveness of ZERONA. In fact, ZERONA is the only body contouring device awarded FDA market clearance based on Level 1 research. Level 1 research is the most stringent of the FDA’s efficacy testing standards involving double-blind, randomized, multi-site and placebo controlled studies, similar to those conducted by pharmaceutical companies.

What Can Patients Expect?

Clinical research submitted to the FDA demonstrated that with ZERONA alone, patients, on average, lost 3.5 inches in circumference off hips, waist and thighs. Now with over 20,000 patients treated across the United States and Canada, the average inch reduction increased to 4.2” off these same measurement areas by asking patients to adhere to a comprehensive protocol, which emphasizes hydration and lymphatic system mobilization. Both of which aid in the body’s ability to rid itself of the excess fat.

Is ZERONA® Safe?

A study was performed using ZERONA® to check cholesterol and triglyceride levels. None of the patients demonstrated a statistically significant elevation in their triglycerides and cholesterol levels. In fact a statistically significant reduction in both low density lipids (LDL) and cholesterol levels was observed. So far, over 20,000 patients have been treated with ZERONA® with no reported side effects or complications.

What Type of Patients Can Be Treated?

Essentially all parts of the body where subcutaneous deposits of fat can be found may be treated with ZERONA®, especially those resistant to diet and exercise. Most patients start with treating their waist, hips and thighs as these can be treated simultaneously with the 5 lasers of ZERONA®. All patients can benefit from Zerona®, from the very trim all the way to the clinically obese. However, the number of treatments and clinical protocols will vary depending on the patient. For instance, clinically obese patients will often combine Zerona with a program of weight loss and exercise. The significant improvement in body shape over a short period of time is used to motivate patients to comply with their diet and exercise program.

Science of ZERONA®

From Theory to Therapy

ZERONA® utilizes the Erchonia® Laser Scanner, the safest and most researched low-level laser in the world. Initially designed and FDA approved for use during liposuction, the non-invasive Erchonia laser is applied to emulsify the adipose tissue and release excess fat into the interstitial space. From there, fat is passed through the body during its normal course of detoxification.

Whether performing traditional liposuction procedures or following the new ZERONA® protocol, physicians can be confident they are treating their patients with the safest and most researched low level laser in the world.

The ZERONA® procedure has been proven through a double-blind, randomized, multi-site and placebo-controlled clinical study in which patients, on average, lost 3.64 inches from their waist, hips, and thighs. These results were dramatic compared to the placebo group, which only lost an average of half an inch over the same time period.

This animation shows:

• Healthy adipose cells
• Fat droplets seeping from the cell membrane
• Collapse of adipose cell-emulsification

The remarkable images above demonstrate the low-level laser's ability to emulsify adipose tissue. The pictures highlight the safe collapse of the rigid adipose cell and the secretion of triglycerides and fatty acid from the cell.

How Triglycerides and Fatty Acids Escape with ZERONA®

These images show the formation of a transitory pore forming in the bi-lipid membrane of an adipose cell. This pore is the direct result of safe, low-level laser stimulation and the reason why the triglycerides and fatty acids are able to move into the interstitial space. The tiny pore causes no damage to the cell. It simply allows the fatty content to safely evacuate the cell.

The ZERONA® process is well supported by scientific research and analysis. The specification configurations for ZERONA® are:

• Configuration: 5-3b Line Generated Laser Diode Modules
• Wavelength: 635nm
• Modulation Constant Wave (CW)-1,000 Hz
• Programming: 4 Time Saving Preset Programs
• Display: 8" Full Color TFT Touch Panel Control Center
• Adjustments 44" Vertical Arm Height Adjustment
• Power Source 100-240VAC 50-60Hz
• Chassis: Powder Coated Metal Frame for Ease of Cleaning, 4 Anti-Static Casters (2 Locking)
• Housing: Thermoformed of Non-Allergen Material/Plastic
• Accessories 2-Keys, Laser Safety Glasses